B. Perry

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

J. O’Shea, A. Milici, B. Reitz, 2003, Science.

Hemodynamics in transgenic mice with overexpression of atrial natriuretic factor.

J. Murgo, R. Re, L. Field, 1994, Circulation research.

Antagonizing leukotriene B4 receptors delays cardiac allograft rejection in mice.

E. J. Weringer, H. Showell, S. Gilman, 1999, Transplantation.

Transgenic Mice With Overexpression of Atrial Natriuretic Factor

J. Murgo, R. Re, L. Field, 2005 .

The Novel JAK‐3 Inhibitor CP‐690550 Is a Potent Immunosuppressive Agent in Various Murine Models

P. Changelian, W. Brissette, M. Conklyn, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE(-/-) mice.

A. Kalgutkar, D. Knight, R. Gladue, 2010, Atherosclerosis.

Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection.

M. Hines, M. Munchhof, P. Changelian, 2010, Journal of medicinal chemistry.

Microsphere and dilution techniques for the determination of blood flows and volumes in conscious mice.

J. Murgo, R. Re, J P Murgo, 1992, The American journal of physiology.

Prior arterial injury enhances luciferase expression following in vivo gene transfer.

J. Murgo, J. Cook, R. Re, 1993, Biochemical and Biophysical Research Communications - BBRC.

Combination of dobutamine and myocardial contrast echocardiography to differentiate postischemic from infarcted myocardium.

J. Murgo, J. Cheirif, M. Meza, 1997, Journal of the American College of Cardiology.

Myocardial contrast echocardiography: reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent.

J. Murgo, J. Cheirif, M. Meza, 1996, American heart journal.